Literature DB >> 33012740

Phenotypic Changes in Macrophage Activation in a Model of Nonalcoholic Fatty Liver Disease using Microminipigs.

Daiki Yoshii1, Takenobu Nakagawa1, Yoshihiro Komohara1,2, Hiroaki Kawaguchi3, Sohsuke Yamada4, Akihide Tanimoto5.   

Abstract

AIM: Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver disorders associated with metabolic syndrome, and its prevalence has been on the rise. The pathogenesis of NAFLD has not yet been sufficiently elucidated due to the multifactorial nature of the disease, although the activation of macrophages/Kupffer cells is considered to be involved. We previously reported an animal model of NAFLD using MicrominipigsTM (µMPs) fed high-fat diets containing cholesterol with or without cholic acid. The aim of this study was to investigate the phenotypic changes of macrophages that occur during the development of NAFLD.
METHODS: Immunohistochemistry of macrophages, lymphocytes, and stellate cells was performed using liver samples, and the density of positive cells was analyzed.
RESULTS: The number of Iba-1-positive macrophages increased with increasing cholesterol content in the diet. The numbers of CD163-positive macrophages and CD204-positive macrophages also increased with increasing cholesterol content in the diet; however, the proportion of CD204-positive macrophages among Iba-1-positive macrophages was significantly reduced by cholic acid supplementation.
CONCLUSION: The results suggest that lipid accumulation induced macrophage recruitment in swine livers, and that the number of M2-like macrophages increased at the early stage of NAFLD, while the number of M1-like macrophages increased at the late stage of NAFLD, resulting in a liver condition like non-alcoholic steatohepatitis. We provide evidence of the phenotypic changes that occur in macrophages during the development of NAFLD that has never been reported before using µMPs.

Entities:  

Keywords:  Fatty liver disease; Macrophage; Microminipig; NAFLD; NASH

Mesh:

Substances:

Year:  2020        PMID: 33012740      PMCID: PMC8326174          DOI: 10.5551/jat.57703

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  37 in total

Review 1.  Alternative activation of macrophages.

Authors:  Siamon Gordon
Journal:  Nat Rev Immunol       Date:  2003-01       Impact factor: 53.106

2.  Oxidized LDL enhances pro-inflammatory responses of alternatively activated M2 macrophages: a crucial role for Krüppel-like factor 2.

Authors:  L J H van Tits; R Stienstra; P L van Lent; M G Netea; L A B Joosten; A F H Stalenhoef
Journal:  Atherosclerosis       Date:  2010-11-27       Impact factor: 5.162

3.  Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.

Authors:  Zobair M Younossi; Maria Stepanova; Mariam Afendy; Yun Fang; Youssef Younossi; Hesham Mir; Manirath Srishord
Journal:  Clin Gastroenterol Hepatol       Date:  2011-03-25       Impact factor: 11.382

Review 4.  Macrophage phenotypes in atherosclerosis.

Authors:  Sophie Colin; Giulia Chinetti-Gbaguidi; Bart Staels
Journal:  Immunol Rev       Date:  2014-11       Impact factor: 12.988

5.  Optimum immunohistochemical procedures for analysis of macrophages in human and mouse formalin fixed paraffin-embedded tissue samples.

Authors:  Takenobu Nakagawa; Koji Ohnishi; Yui Kosaki; Yoichi Saito; Hasita Horlad; Yukio Fujiwara; Motohiro Takeya; Yoshihiro Komohara
Journal:  J Clin Exp Hematop       Date:  2017

Review 6.  Mechanisms of hepatic stellate cell activation.

Authors:  Takuma Tsuchida; Scott L Friedman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-10       Impact factor: 46.802

7.  Liver myofibroblasts regulate infiltration and positioning of lymphocytes in human liver.

Authors:  Andrew P Holt; Emma L Haughton; Patricia F Lalor; Andrew Filer; Christopher D Buckley; David H Adams
Journal:  Gastroenterology       Date:  2008-10-15       Impact factor: 22.682

8.  Formation of p62-positive inclusion body is associated with macrophage polarization in non-alcoholic fatty liver disease.

Authors:  Hirofumi Fukushima; Shunhei Yamashina; Atsushi Arakawa; Gentaro Taniguchi; Tomonori Aoyama; Akira Uchiyama; Kazuyoshi Kon; Kenichi Ikejima; Sumio Watanabe
Journal:  Hepatol Res       Date:  2018-04-10       Impact factor: 4.288

9.  Macrophages: central regulators of hepatic fibrogenesis and fibrosis resolution.

Authors:  Prakash Ramachandran; John P Iredale
Journal:  J Hepatol       Date:  2012-02-04       Impact factor: 25.083

10.  C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis.

Authors:  Amrom E Obstfeld; Eiji Sugaru; Marie Thearle; Anne-Marie Francisco; Constance Gayet; Henry N Ginsberg; Eleanore V Ables; Anthony W Ferrante
Journal:  Diabetes       Date:  2010-01-26       Impact factor: 9.461

View more
  1 in total

Review 1.  Macrophage Polarization and Its Role in Liver Disease.

Authors:  Cheng Wang; Cheng Ma; Lihong Gong; Yuqin Guo; Ke Fu; Yafang Zhang; Honglin Zhou; Yunxia Li
Journal:  Front Immunol       Date:  2021-12-14       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.